GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Itoco Inc (OTCPK:ITMC) » Definitions » Tax Provision

Itoco (ITMC) Tax Provision : $-0.15 Mil (TTM As of Sep. 2010)


View and export this data going back to 2009. Start your Free Trial

What is Itoco Tax Provision?

Itoco's tax provision for the three months ended in Sep. 2010 was $0.00 Mil. Its tax provision for the trailing twelve months (TTM) ended in Sep. 2010 was $-0.15 Mil.


Itoco Tax Provision Historical Data

The historical data trend for Itoco's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Itoco Tax Provision Chart

Itoco Annual Data
Trend Dec08 Dec09
Tax Provision
-0.67 -0.02

Itoco Quarterly Data
Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.01 -0.07 0.02 -0.11 -

Itoco Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Sep. 2010 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Itoco (ITMC) Business Description

Traded in Other Exchanges
N/A
Address
50 West Liberty Street, Suite 880, Reno, NV, USA, 89501
Itoco Inc is focused on developing and bringing biotech products to the market via co-development and joint venture arrangements with various companies. The company is currently examining various technologies that seek to control and/or identify bio-contaminants such as viruses and bacteria.